DGX

  
 
 
Quest Diagnostics Incorporated

Dividend Growth

Min. Div. Growth Past 7 Yrs. ≥ 15%: 9.0
Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 7.1%
Years of Div. Growth ≥ 15: 20

Income Generation

Current Yield 1.9≥ 20-Yrs Treasury Yield 4.0
Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs

Sustainability

Debt-To-Equity 0.40 ≤ 0.45 
Last 12Months Cash Payout 0.37 ≤ 0.6 

Profitability

5-Yr Avg. Return-on-Equity 19.3≥ 15%
Last 12Months Return-on-Equity 12.8≥ 15%
Last 12Months Net Profit Margin 9.0≥ 10% 

Fair Value

Average 5-Yrs High Yield 2.6%
Current Price $154.4 ≤ High Yield Price $115.3
Average 5-Yrs Price-to-Earning (P/E) 13.5
Current Price $154.4 ≤ Average P/E Price $100.1
Current Price $154.4 ≤ Fair Value $98.9 

Company Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Dividend

Revenue

Earning

Free Cash Flow